Neuroleptics attentuate stereotyped behavior induced by beta-phenylethylamine in rats. 1978

E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt

UI MeSH Term Description Entries
D008297 Male Males
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D010868 Pimozide A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403) Antalon,Orap,Orap forte,R-6238,R6238
D011954 Receptors, Dopamine Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells. Dopamine Receptors,Dopamine Receptor,Receptor, Dopamine
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D003024 Clozapine A tricylic dibenzodiazepine, classified as an atypical antipsychotic agent. It binds several types of central nervous system receptors, and displays a unique pharmacological profile. Clozapine is a serotonin antagonist, with strong binding to 5-HT 2A/2C receptor subtype. It also displays strong affinity to several dopaminergic receptors, but shows only weak antagonism at the dopamine D2 receptor, a receptor commonly thought to modulate neuroleptic activity. Agranulocytosis is a major adverse effect associated with administration of this agent. Clozaril,Leponex
D003975 Diazepam A benzodiazepine with anticonvulsant, anxiolytic, sedative, muscle relaxant, and amnesic properties and a long duration of action. Its actions are mediated by enhancement of GAMMA-AMINOBUTYRIC ACID activity. 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one,Apaurin,Diazemuls,Faustan,Relanium,Seduxen,Sibazon,Stesolid,Valium
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation

Related Publications

E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
June 1979, Life sciences,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
November 1970, The Journal of pharmacy and pharmacology,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
November 1978, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
January 1977, Experientia,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
June 2020, Biochemical and biophysical research communications,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
December 1973, Japanese journal of pharmacology,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
January 1969, Psychopharmacologia,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
July 1982, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
January 1971, European journal of pharmacology,
E A Moja, and D M Stoff, and J C Gillin, and R J Wyatt
May 1997, Progress in neuro-psychopharmacology & biological psychiatry,
Copied contents to your clipboard!